Omega Laboratory

Montreal, Canada Founded: 1958 • Age: 68 yrs Acquired By Sagent Pharma
Specialized sterile products are manufactured for hospitals and providers.
Annual revenue - Latest available
Total funding - Funding intelligence
Employees - Tracked headcount
Investors 1 Known backers
Products 5 Services tracked
Competitors - Brand Intelligence

About Omega Laboratory

Omega Laboratory is a company based in Montreal (Canada) founded in 1958 was acquired by Sagent Pharma in October 2014. Omega Laboratory offers products and services including Diltiazem Hydrochloride Injection, Bupivacaine Hydrochloride in Dextrose Injection, Dextrose Injection, Caffeine Citrate Injection, and Caffeine Citrate Oral Solution.

  • Headquarter Montreal, Canada
  • Sectors
    Healthcare
  • Email
    Locked
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
  • Legal Name Omega Laboratories Limited
  • Jurisdiction Delhi, Delhi, India
Operational Areas
Healthcare → Healthcare Services & Infrastructure Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    -$3.79 K (USD)
    -303.52
    as on Mar 31, 2022
  • EBITDA
    -$3.78 K (USD)
    -303.16
    as on Mar 31, 2022
  • Latest Funding Round
    Not available
  • Investors
  • Employee Count
    Not available
  • Acquired by
    Sagent Pharma

    (Oct 01, 2014)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Omega Laboratory

Omega Laboratory offers a comprehensive portfolio of products and services, including Diltiazem Hydrochloride Injection, Bupivacaine Hydrochloride in Dextrose Injection, Dextrose Injection, Caffeine Citrate Injection, and Caffeine Citrate Oral Solution.

Product name locked
Category locked
Primary

Injectable solution for cardiovascular treatment.

Product name locked
Category locked
Locked

Anesthetic for pain management during procedures.

Product name locked
Category locked
Locked

Solution used for nutritional or fluid therapy.

Product name locked
Category locked
Locked

Injectable for neonatal respiratory support.

Product name locked
Category locked
Locked

Oral solution for treating apnea in infants.

Funding Insights of Omega Laboratory

Premium access

Detailed funding history for Omega Laboratory

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investors in Omega Laboratory

Omega Laboratory has secured backing from 1 investor. Prominent investors backing the company include Sagent Pharma.

All
Investor Description Founded Year Domain Location
Injectable generic pharmaceuticals are supplied across multiple therapeutic categories.
Locked Locked Locked
Premium access

Investor details for Omega Laboratory

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Omega Laboratory

Investments
Premium access

Investment portfolio details for Omega Laboratory

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Omega Laboratory

Premium access

Detailed financials for Omega Laboratory

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Omega Laboratory Comparisons

Omega Laboratory Primary company
Description
Specialized sterile products are manufactured for hospitals ...
Location
Montreal, Canada
Founded Year
1958
Annual Revenue
Not available
Net Profit
-$3.79 K (USD)
EBITDA
-$3.78 K (USD)
Employees
Not available
Premium access

Peer comparison for Omega Laboratory

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Omega Laboratory

Premium access

Detailed competitors of Omega Laboratory

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Omega Laboratory

Premium access

Complete news archive for Omega Laboratory

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Omega Laboratory

Omega Laboratory was founded in 1958.

Omega Laboratory is headquartered in Montreal, Canada. It is registered at Montreal, Quebec, Canada.

Bruce Levins is the current CEO of Omega Laboratory.

Omega Laboratories is a manufacturer of specialized products for hospitals. It is also a contract manufacturing organization, offering custom manufacturing of injectable and non-injectable sterile products and services including formulation, development of analytical methods, lab batch, pilot and small lot production, stability, process validation, packaging, and distribution. Their Hospital products include injectables for oncology, respiratory diseases, CNS diseases, vitaminmineral supplements, non-injectables such as antacids, laxatives, keratolytic agents, etc.

Omega Laboratory offers Diltiazem Hydrochloride Injection, Bupivacaine Hydrochloride in Dextrose Injection, Dextrose Injection, Caffeine Citrate Injection, and Caffeine Citrate Oral Solution.

Omega Laboratory has 1 investor. Key investors include Sagent Pharma.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available